BioCentury
ARTICLE | Financial News

Anemia company Akebia files for IPO

February 15, 2014 1:18 AM UTC

Akebia Therapeutics Inc. (Cambridge, Mass.) filed to raise up to $75 million in an IPO on NASDAQ underwritten by Morgan Stanley; Credit Suisse; UBS; and Nomura. Akebia is evaluating AKB-6548 in a Phas...